Therapy Areas: AIDS & HIV
South Korea approves remdesivir as treatment for COVID-19
3 June 2020 -

BBC News reported on Wednesday that South Korea has approved the import of remdesivir, a drug that appears to shorten recovery time for people with COVID-19.

Reportedly, remdesivir cuts the duration of symptoms from 15 days down to 11 in clinical trials at hospitals around the world.

The drug is already approved for treatment of COVID-19 in the US, Japan and India.

According to the BBC, remdesivir is an anti-viral medicine that has been used against Ebola. Other drugs being investigated include medication used for malaria and HIV.

Login
Username:

Password: